Savient Pharmaceuticals Inc

Formerly NASDAQ: SVNT
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 5 pages Form of Incentive Bonus Agreement
12/34/56
EX-10.1
from 8-K 28 pages Confidential Separation Agreement and General Release
12/34/56
EX-10.1
from 8-K 23 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 30 pages Confidential Treatment Has Been Requested for Portions of This Document Indicated by [***], Which Portions Are Filed Separately With the Commission. Amended and Restated Employment Agreement
12/34/56
EX-10.3
from 8-K 42 pages Warrant Agreement Dated as of May 9, 2012 Between Savient Pharmaceuticals, Inc. and U.S. Bank National Association, as Warrant Agent
12/34/56
EX-10.2
from 8-K 30 pages Pledge and Security Agreement Dated as of May 9, 2012 by and Among Savient Pharmaceuticals, Inc., Each of the Other Grantors Party Hereto and U.S. Bank National Association, as Collateral Agent
12/34/56
EX-10.1
from 8-K 13 pages Exchange and Purchase Agreement
12/34/56
EX-10.38
from 10-K 62 pages Office Lease Agreement by and Between Wells REIT – Multi-State Owner, LLC and Savient Pharmaceuticals, Inc. Bridgewater Crossing 400 Crossing Boulevard Bridgewater, New Jersey
12/34/56
EX-10.37
from 10-K 31 pages Dated: 11 January 2012 (1) Savient Pharma Ireland Limited (2) David Veitch Service Agreement Service Agreement Dated 11 January 2012 Between: 1 Parties (1) Savient Pharma Ireland Limited of Mespil Business Centre, Mespil House, Sussex Road, Dublin 4, Republic of Ireland (Registered With the Irish Companies Registration Office Under Number 492194) (‘The Company’) (2) David Veitch of Hamilton Lodge, 6 Shillingridge Park, Frieth Road, Marlow, Bucks, Sl7 2qx (‘The Executive’) 2 Interpretation
12/34/56
EX-10.34
from 10-K 22 pages Employment Agreement
12/34/56
EX-10.33
from 10-K 23 pages Employment Agreement
12/34/56
EX-10.32
from 10-K 23 pages Employment Agreement
12/34/56
EX-10
from 8-K ~20 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 22 pages Employment Agreement
12/34/56
EX-10.1
from 8-K ~5 pages Separation and General Release Agreement
12/34/56
EX-10.1
from 10-Q 23 pages Employment Agreement
12/34/56
EX-10.42
from 10-K 23 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 24 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Consulting Services Agreement Between Savient Pharmaceuticals, Inc. and Lee S. Simon, MD
12/34/56
EX-10.2
from 8-K 16 pages Savient Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56